D001 Derm Tank
DESCRIPTION
In this Derm Tank session presenters will pitch their dermatology-related ideas with commercial potential including new techniques, devices, products or instruments to a panel of esteemed judges. The presentations will be scored for innovation and commercial viability. The highest-rated presenter will receive a "seed" money honorarium.
Come join us to see our 3 finalists present the following innovations:
1. Dr. Neil Jairath and Dr. Vignesh Ramachandran: DermFlow
2. Dr. Abraham Abdulhak: Solar Rolar
3. Dr. Katherine Lee: CryoCaptures
This session is not certified for AMA PRA Category 1 CME Credit.
LEARNING OBJECTIVES
Apply novel and innovative technology to everyday dermatology practice.
Introduce products for patients that improve their dermatology care.
Determine the best commercially viable novel efforts that are likely to make it to market.
SCHEDULE
9:00 PM
Welcome & Introduction
Mark D. Kaufmann, MD, FAAD
9:05 PM
DermFlow
Neil K. Jairath, MD, Vignesh Ramachandran, MD, FAAD
9:22 PM
Panel Q&A
Mark D. Kaufmann, MD, FAAD, Ashish Bhatia, MD, FAAD, Arianne Shadi Kourosh, MD, MPH, FAAD
9:27 PM
Solar Roller
Abraham Abdulhak, MD, FAAD
9:44 PM
Panel Q&A
Mark D. Kaufmann, MD, FAAD, Ashish Bhatia, MD, FAAD, Arianne Shadi Kourosh, MD, MPH, FAAD
9:49 PM
CryoCaptures
Katherine B. Lee, MD, FAAD
10:06 PM
Panel Q&A
Mark D. Kaufmann, MD, FAAD, Ashish Bhatia, MD, FAAD, Arianne Shadi Kourosh, MD, MPH, FAAD
10:11 PM
2024 Derm Tank Winner Update
Justin W. Marson, MD
10:16 PM
Judging Deliberation
Mark D. Kaufmann, MD, FAAD, Ashish Bhatia, MD, FAAD, Arianne Shadi Kourosh, MD, MPH, FAAD
10:26 PM
Winner Announcement & Closing
Mark D. Kaufmann, MD, FAAD
SPEAKERS
Abraham Abdulhak, MD, FAAD
Dermatology Institute of Detroit
Ashish Bhatia, MD, FAAD
Oak Dermatology
Neil K. Jairath, MD
New York University
Mark D. Kaufmann, MD, FAAD
Arianne Shadi Kourosh, MD, MPH, FAAD
Harvard Medical School / Harvard Chan School of Public Health
Katherine B. Lee, MD, FAAD
Halcyon Dermatology
Justin W. Marson, MD
Vignesh Ramachandran, MD, FAAD
Skin Institute of New York
SPEAKER DISCLOSURES
Abraham Abdulhak, MD, FAAD
No financial relationships exist with ineligible companies.
Ashish Bhatia, MD, FAAD
AbbVie – Other(Grants/Research Funding), Stockholder Public Company(Stock Options); Alastin Skincare, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc – Advisory Board(Honoraria), Speaker(Honoraria); Allergan, Inc. – Consultant(Honoraria); Arcutis Biotherapeutics – Consultant (1099 relationship)(Fees); Avita Medical – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Bausch Health – Consultant (1099 relationship)(Fees), Stockholder Public Company(Stock); BioMarck Pharmaceuticals, Ltd. – Advisory Board(No Compensation Received), Board of Directors(Honoraria), Stockholder(No Compensation Received); Bristol-Myers Squibb – Advisory Board(Honoraria); Caliway Biopharmaceuticals Co., Ltd – Advisory Board(No Compensation Received); Carpe – Consultant (1099 relationship)(Fees), Stockholder Private Company(Stock Options); Cutera, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Other(Grants/Research Funding), Speaker(Honoraria), Stockholder(Stock); Cynosure-Lutronic – Advisory Board(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(Honoraria), Consultant(Honoraria), Stockholder Public Company(No Compensation Received); Derm Education Foundation – Advisory Board(Honoraria), Speaker(Honoraria); Derm.md, Inc. – Board of Directors(No Compensation Received), Stockholder(No Compensation Received); Eli Lilly – Other(Grants/Research Funding); Elsevier Inc. – Consultant(Honoraria); Emblation, Ltd. – Consultant (1099 relationship)(Fees), Other(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); GenZum Life Sciences – Stockholder(No Compensation Received); Glo-Pharma, Inc. – Consultant (1099 relationship)(Fees); La Mer – Advisory Board(Honoraria); Medline Industries, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Other(Grants/Research Funding), Speaker(Honoraria); MiMedx Group, Inc – Consultant (1099 relationship)(Fees), Speaker(Honoraria); Novascan – Other(Grants/Research Funding); Obagi Medical – Consultant (1099 relationship)(Fees); Obagi Medical Products – Consultant (1099 relationship)(Fees); Ortho Dermatologics – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); OurSelf – Board of Directors(No Compensation Received); Ourself – Consultant (1099 relationship)(Fees); Paradigm Medical Communications, LLC – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pulse Biosciences – Other(Grants/Research Funding); R2 Technologies – Other(Grants/Research Funding); RBC Consultants – Consultant (1099 relationship)(Fees); Revance Therapeutics, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sentient Lasers – Speaker(Fees); SimSkin – Stockholder(No Compensation Received); SofWave – Consultant (1099 relationship)(Fees); Sol Science – Other(No Compensation Received); Solta Medical – Advisory Board(Honoraria), Consultant(Honoraria); Sonoma Pharmaceuticals – Stockholder Public Company(No Compensation Received); Strata Skin Sciences – Advisory Board(Honoraria), Stockholder Public Company(Stock Options); Theravant Corporation – Advisory Board(Honoraria), Board of Directors(No Compensation Received), Speaker(Honoraria), Stockholder(No Compensation Received); Zalea, LLC – Stockholder Private Company(No Compensation Received);
Neil K. Jairath, MD
No financial relationships exist with ineligible companies.
Mark D. Kaufmann, MD, FAAD
Almirall – Consultant (1099 relationship)(Fees); Apogee Therapeutics – Consultant (1099 relationship)(Fees); Biofrontera – Consultant (1099 relationship)(Fees); Botanix Pharmaceuticals – Advisory Board(Fees); DermTech Inc. – Consultant (1099 relationship)(Fees); Feldan Therapeutics – Consultant (1099 relationship)(Fees); Incyte – Consultant (1099 relationship)(Fees); Novartis – Consultant (1099 relationship)(Fees); Oruka Therapeutics – Consultant (1099 relationship)(Fees); Peerwise Medical Corp – Stockholder Private Company(Stock Options); Pelthos Therapeutics – Consultant (1099 relationship)(Fees); Sanofi/Regeneron – Consultant (1099 relationship)(Fees); SciBASE – Consultant (1099 relationship)(Fees); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB Pharma – Consultant (1099 relationship)(Fees); VeraDermics Inc. – Advisory Board(Fees); Verrica Pharmaceuticals Inc – Consultant (1099 relationship)(Fees);
Arianne Shadi Kourosh, MD, MPH, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Guidepoint Global, LLC – Consultant(Fees); L'Oreal – Consultant (1099 relationship)(Fees); Ortho Dermatologics – Consultant(Fees); Unilever – Consultant(Fees);
Katherine B. Lee, MD, FAAD
Botanix Pharmaceuticals – Speaker(Fees); CorEvitas – Investigator(Grants/Research Funding); Dermatologist On Call – Advisory Board(Fees); Eli Lilly and Company – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); UCB – Advisory Board(Fees);
Justin W. Marson, MD
American Academy of Dermatology – Other(Grants/Research Funding); Berman Medical – Other(No Compensation Received); Blair & Jack – Consultant(Fees); Castle Biosciences, Inc – Advisory Board(Honoraria); CeraVe/Valeante – Consultant(Honoraria); Doximity Inc. – Advisory Board(Stock); Ferndale Laboratories, Inc. – Advisory Board(Honoraria); La Roche-Posay – Other(Grants/Research Funding); La Roche-Posay Laboratorie Pharmaceutique – Advisory Board(Honoraria);
Vignesh Ramachandran, MD, FAAD
No financial relationships exist with ineligible companies.